SCHEMBL8074288

SCHEMBL8074288

O=C(CC1CC(c2cccc(C(F)(F)F)c2)=CCN1)c1ccc(-c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.44
S1PR5 Q9H228 1/20 0.42
KIF11 P52732 1/20 0.40
SLC6A7 Q99884 1/20 0.40
GHSR Q92847 1/20 0.39
KDM1A O60341 1/20 0.39
PLG P00747 2/20 0.39
PLAU P00749 2/20 0.39
PLAT P00750 2/20 0.39
BACE1 P56817 1/20 0.38
SLC13A5 Q86YT5 1/20 0.38
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
MAOB P27338 1/20 0.37
MME P08473 1/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8507430 0.95 HTR2C (0.41) HTR2CS1PR5KIF11SLC6A7GHSR
SCHEMBL9875803 0.82 HTR2C (0.41) HTR2CCTNNB1WNT3A
SCHEMBL7439313 0.76 MAOB (0.46) HTR2CS1PR5KDM1ABACE1SLC13A5
SCHEMBL9530357 0.76 HTR2C (0.47) HTR2CKDM1AGRIN1GRIN2B
SCHEMBL8540798 0.75 HTR2C (0.44) HTR2CS1PR5KDM1ASLC13A5MAOB
SCHEMBL8543167 0.75 HTR2C (0.44) HTR2CS1PR5KIF11KDM1ABACE1
SCHEMBL7435086 0.75 HTR2C (0.49) HTR2CS1PR5MAOBGRIN1GRIN2B
SCHEMBL9872886 0.74 HTR2C (0.39) HTR2CS1PR5GRIN1GRIN2B
SCHEMBL8023606 0.73 HTR2C (0.41) HTR2CS1PR5KDM1AMAOBGRIN1
SCHEMBL5120102 0.72 HTR2C (0.57) HTR2CKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017385-A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 SANOFI-SYNTHELABO (FR) 2000-07-12 EP disclosed
WO-1998053821-A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1 SANOFI-SYNTHELABO (FR) 1998-12-03 WO disclosed